相关实验视频

Updated: Jul 27, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

小肠腺癌的基因组分析:来自3个数据库的综合分析

Thomas Aparicio¹, Julie Henriques^2,3, Magali Svrcek⁴

¹Department of Gastroenterology and Digestive Oncology, Saint Louis Hospital, APHP, Université de Paris Cité, Paris, France. thomas.aparicio@aphp.fr.

British journal of cancer

|May 14, 2024

概括

小肠腺癌的基因组分析揭示了基于疾病阶段和诱导条件的独特突变模式. 在局部瘤中缺陷不匹配修复 (dMMR) 和APC突变表明更好的预后.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
胃肠病学胃肠病学

背景情况:

小肠腺癌是一种罕见的恶性瘤,其基因组概况和预后因素不清楚.
了解瘤基因组学对于开发向疗法和改善患者治疗结果至关重要.

研究的目的:

为了研究小肠腺癌的基因组景观.
为了将瘤突变概况与临床特征,易感性疾病和患者预后相关联.

主要方法:

来自三个数据库的临床数据,基因组分析和不匹配修复 (MMR) 状态的综合分析.
分析了188个瘤样本,以确定常见的突变及其分布.

主要成果:

KRAS,TP53和APC是最常见的突变. 基因突变模式根据预易性疾病 (例如,林奇综合征,克罗恩病) 有显著的变化.
在转移性瘤中,KRAS和SMAD4突变更为普遍,而ERBB2突变则不存在. 在局部瘤中APC突变与较差的整体存活率有关.
缺陷不匹配修复 (dMMR) 在29.8%的病例中被观察到,并且与更好的整体存活率有关.

结论:

小肠腺癌的基因组概况根据瘤阶段和相关的倾向性状况而有所不同.
局部瘤中的dMMR状态和APC突变是预后的重要预测因素.

更多相关视频

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...